Skip to main content
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRS ISIN · US00461U1051 LEI · 5493000B2LQ9QTW1DF52 US Manufacturing
Filings indexed 844 across all filing types
Latest filing 2025-06-30 Investor Presentation
Country US United States of America
Listing US ACRS

About Aclaris Therapeutics, Inc.

https://www.aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Recent filings

Filing Released Lang Actions
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Aclaris Therapeutics, Inc. It includes an updated corporate overview presentation as Exhibit 99.1. The text explicitly states that the presentation is furnished as an exhibit and is also available on the company's website. The document is short (3860 characters) and primarily serves to announce the furnishing of the presentation rather than containing the presentation itself or detailed financial data. According to the 'Menu vs Meal' rule, such a document is an announcement of a report (presentation) rather than the report itself. Therefore, the appropriate classification is Investor Presentation (IP).
2025-06-30 English
Director's Dealing 2025
Director's Dealing
2025-06-09 English
Director's Dealing 2025
Director's Dealing
2025-06-09 English
Director's Dealing 2025
Director's Dealing
2025-06-09 English
Director's Dealing 2025
Director's Dealing
2025-06-09 English
Director's Dealing 2025
Director's Dealing
2025-06-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.